CD3E and chronic myelogenous leukemia, BCR-ABL1 positive: Chen et al. (8) have reported that decreased expression of both CD3ζ and CD3ε result in an increased ex vivo susceptibility to apoptosis of peripheral blood T cells in patients with chronic myeloid leukemia.